# Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery

> **NCT05871073** · PHASE4 · COMPLETED · sponsor: **University Hospital Fattouma Bourguiba** · enrollment: 60 (actual)

## Conditions studied

- Lumbar Spinal Stenosis
- Lumbar Disc Herniation
- Lumbar Spondylolisthesis
- Lumbar Spine Instability

## Interventions

- **DRUG:** Ropivacaine 0.75% Injectable Solution
- **DRUG:** dexamethasone 8mg

## Key facts

- **NCT ID:** NCT05871073
- **Lead sponsor:** University Hospital Fattouma Bourguiba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-02-04
- **Final completion:** 2023-03-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871073, "Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05871073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*